Drug Database
IM
imatinib mesilate
✓ ApprovedRoche · KIT · Companion diagnostic
What is imatinib mesilate?
imatinib mesilate is a companion diagnostic developed by Roche. It is approved for therapeutic indications via others.
Drug Profile
| Company | Roche |
| Drug Class | Companion diagnostic |
| Molecular Target | KIT |
| Route | Others |
| Status | Approved |
Sources: ClinicalTrials.gov, Roche
Mechanism of Action
Molecular Targets
imatinib mesilate acts on 1 molecular target:
| KIT | KIT proto-oncogene, receptor tyrosine kinase (MASTC, CD117) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
imatinib mesilate is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Uterine cancer | ✓ Approved |
Related Research Articles
Unable to load articles right now.